or
forgot password
  • cancer clinical trials in concord, CA

  • Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Prostate Cancer
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    Mount Diablo Regional Cancer Center
    Concord, California 94524-4110
    Breast Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Lung Cancer
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Head and Neck Cancer
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Head and Neck Cancer, Oral Complications
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Mount Diablo Regional Cancer Center
    Concord, California 94524-4110
    Lymphoma
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Mount Diablo Regional Cancer Center
    Concord, California 94524-4110
    Breast Cancer
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Bladder Cancer
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Prostate Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Brain and Central Nervous System Tumors
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Head and Neck Cancer
    Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer
    East Bay Medical Oncology
    Concord, California 94520
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Endometrial Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Colorectal Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Breast Cancer
    Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Colorectal Cancer
    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    Bay Area Cancer Research Group
    Concord, California 94520
    Chronic Lymphocytic Leukemia
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
    East Bay Medical Oncology Hematology Associates
    Concord, California 94520
    Pancreatic Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Head and Neck Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Colorectal Cancer
    Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Breast Cancer, Lymphedema, Perioperative/Postoperative Complications
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Breast Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Breast Cancer, Fatigue, Sleep Disorders
    Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Colorectal Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Endometrial Cancer, Fatigue, Neurotoxicity
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Lung Cancer
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Bay Area Cancer Research Group
    Concord, California 94520
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Ovarian Cancer, Sarcoma
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Colorectal Cancer, Precancerous Condition
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
    Bay Area Cancer Research
    Concord, California 94520
    Multiple Myeloma
    AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Fallopian Tube Cancer, Ovarian Cancer, Malignant Tumor of Peritoneum
    Connect® MM- The Multiple Myeloma Disease Registry
    Bay Area Cancer Research Group, LLC
    Concord, California 94520
    Multiple Myeloma
    Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Cervical Cancer, Endometrial Cancer, Sarcoma
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Colorectal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Study of PX-866 and Docetaxel in Solid Tumors
    Bay Area Cancer Research Group, LLC
    Concord, California 94520
    Non Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
    Bay Area Cancer Research Dept.ofBayAreaCancerResearch
    Concord, California 94520
    Chronic Myelogenous Leukemia in Chronic Phase
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
    John Muir Clinical Research Center
    Concord, California 94520
    Endometrial Cancer
    Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Cervical Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexuality and Reproductive Issues
    Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome
    Bay Area Cancer Research Group
    Concord, California 94520
    Myelodysplastic Syndrome (MDS)
    Caris Biorepository Research Protocol
    John Muir Clinical Research Center
    Concord, California 94520
    Cancer
    Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Colorectal Cancer